8-K

Company

Prelude Therapeutics Inc

Filed

April 10, 2024

Period of Report

April 8, 2024

Accession Number

0000950170-24-043347

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →